Smith & Nephew plc filed a Form 6-K on November 11, 2026, disclosing purchases of ordinary shares by its Chief Executive Officer and four other persons discharging managerial responsibilities through the company's Dividend Re-Investment Plan following the 2026 interim dividend payment.

Key Highlights

  • Transaction date: All purchases occurred on November 6, 2026, on the London Stock Exchange (XLON).
  • Instrument: Smith & Nephew plc ordinary shares of USD 0.20 each (ISIN: GB0009223206).
  • Price per share: 11.676693 (as stated in the filing) for all five transactions.
  • CEO purchase: Deepak Nath (Chief Executive Officer) acquired a volume of 4354.91595 shares through the plan.
  • Other participants: Scott Schaffner (President, Sports Medicine) acquired 1400.18596; Paul Connolly (President, Global Operations) acquired 775.61555; Ajay Dhankhar (Chief Strategy & Corporate Development Officer) acquired 210.78942; and Alison Parkes (Chief Compliance Officer) acquired 100.10139.
  • Nature of transactions: Each is described as a purchase through the company's Dividend Re-Investment Plan following the 2026 interim dividend payment on November 6, 2026, and each is classified as a single transaction.

Smith & Nephew DRIP Transactions Following 2026 Interim Dividend

According to the filing, the notification is made in accordance with the UK Market Abuse Regulation (Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018) and constitutes an initial notification. The disclosure covers transactions by one director and four persons discharging managerial responsibilities (PDMRs) at Smith & Nephew plc, listed on the exchange under Commission File Number 001-14978.

The filing reports that all five individuals acquired ordinary shares at a price of 11.676693 per share on November 6, 2026, through the company's Dividend Re-Investment Plan following the 2026 interim dividend payment on that same date. The transactions took place on the London Stock Exchange (XLON). Each transaction is described in the filing as a single transaction with no aggregated grouping across individuals.

The five participants and their respective volumes, as disclosed, are: Deepak Nath (Chief Executive Officer, Director) at 4354.91595; Scott Schaffner (President, Sports Medicine, PDMR) at 1400.18596; Paul Connolly (President, Global Operations, PDMR) at 775.61555; Ajay Dhankhar (Chief Strategy & Corporate Development Officer, PDMR) at 210.78942; and Alison Parkes (Chief Compliance Officer, PDMR) at 100.10139. The filing was signed on behalf of the registrant by Helen Barraclough, Company Secretary, on November 11, 2026.

What Was Disclosed

Smith & Nephew plc disclosed that five senior individuals, including its CEO, acquired ordinary shares on November 6, 2026, via the company's Dividend Re-Investment Plan at a price of 11.676693 per share, in connection with the 2026 interim dividend payment.